NCT07209774

Brief Summary

Healthspan Connect is a new research programme designed to understand what helps people stay healthy as they age. The programme will explore how lifestyle, environment, genetics, and social factors influence healthy ageing and overall wellbeing. The programme will recruit participants aged 12 years and older across the UK. By including adolescents, the programme aims to understand how early life behaviours and experiences shape long-term health. There is no upper age limit, and people from all backgrounds are encouraged to participate. Special pathways ensure that young participants provide consent in an age-appropriate way. Healthspan Connect is a digital and home-based study, meaning participants can take part from home using smartphones, computers, and online surveys. Participants may also be asked to collect samples such as blood, saliva, stool, urine, or other biological specimens at home using easy-to-use kits. In some sub-studies, participants may be invited to attend research visits for additional tests, scans, or clinical assessments. Family members and close contacts may also be invited to participate in some studies. Through Healthspan Connect, researchers aim to:

  • Identify the biological, environmental, and social factors that help people live longer, healthier lives.
  • Understand how different groups, including those historically underrepresented in research, experience ageing.
  • Explore ways to support behaviour changes that improve health over the lifespan.
  • Provide near real-time information to inform health policies and interventions. Participants may also be asked for permission to link their information with health records, education records, and environmental data to better understand health outcomes over time. This programme will serve as a flexible platform for multiple sub-studies, allowing participants to contribute to a wide range of research questions related to healthy ageing, resilience, and long-term health. All data and biological samples will be stored securely and used to advance scientific knowledge, with participant privacy carefully protected.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100,000

participants targeted

Target at P75+ for all trials

Timeline
361mo left

Started Jan 2026

Longer than P75 for all trials

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress1%
Jan 2026Jan 2056

First Submitted

Initial submission to the registry

September 26, 2025

Completed
11 days until next milestone

First Posted

Study publicly available on registry

October 7, 2025

Completed
3 months until next milestone

Study Start

First participant enrolled

January 5, 2026

Completed
30 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 5, 2056

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 5, 2056

Last Updated

October 7, 2025

Status Verified

September 1, 2025

Enrollment Period

30 years

First QC Date

September 26, 2025

Last Update Submit

September 29, 2025

Conditions

Keywords

Healthy ageingHealthspanLongevityAgeing resilienceLife course determinantsMultiple long-term conditionsDigital health researchRemote monitoringMobile health (mHealth)WearablesBiobankBiological specimen collectionHome-based sample collectionEpidemiologyLongitudinal cohort studyAdolescents and ageingUnderrepresented populations in researchBehaviour changeEnvironmental exposuresData linkageElectronic health records (EHR)United Kingdom

Outcome Measures

Primary Outcomes (2)

  • Incidence of early-onset colorectal cancer (EOCRC)

    Primary outcome for the first sub-study under the Healthspan Connect programme of research (PROSPECT UK). Defined as a new diagnosis of colorectal cancer before age 50. Confirmed via data from Electronic Health Record Linkage.

    Through study completion, anticipated ≥10 years

  • Incidence of early-onset colorectal adenoma (EOCA)

    Primary outcome for the first sub-study under the Healthspan Connect programme of research (PROSPECT UK). Defined as a new diagnosis of colorectal adenoma before age 50. Confirmed via data from Electronic Health Record Linkage.

    Through study completion, anticipated ≥10 years

Eligibility Criteria

Age12 Years+
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study will recruit a large, diverse population of UK residents aged 12 years and older, including adolescents, young adults, and adults across the life course. Participants will be drawn from the general population through open digital recruitment methods and will not be limited by specific disease status. The cohort aims to reflect the socioeconomic, geographic, and ethnic diversity of the UK, with particular efforts to include groups typically underrepresented in health research.

You may qualify if:

  • Age 12 years or older at time of enrollment.
  • Resident in the United Kingdom.
  • Able to participate in the study using digital tools (smartphone, tablet, or computer).
  • Able to provide informed consent (digital consent accepted).
  • For participants aged 12-15 years: must have parent/guardian consent in addition to their own assent.

You may not qualify if:

  • Individuals unable to provide informed consent (or parental consent where applicable).
  • Individuals not resident in the UK.
  • Individuals unable to complete study requirements due to lack of internet access, inability to use digital devices, or severe digital literacy barriers.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

NeoplasmsPsychological Well-BeingHypersensitivity

Condition Hierarchy (Ancestors)

Personal SatisfactionBehaviorImmune System Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 26, 2025

First Posted

October 7, 2025

Study Start

January 5, 2026

Primary Completion (Estimated)

January 5, 2056

Study Completion (Estimated)

January 5, 2056

Last Updated

October 7, 2025

Record last verified: 2025-09